Cresset Asset Management’s ImmuCell ICCC Stock Holding History

Cresset Asset Management’s Portfolio ICCC Stock Details ICCC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.36M	Hold	135,267	–	–	﹤0.01%	791
2026 Q1	$856K	Hold	135,267	–	–	﹤0.01%	843
2025 Q4	$832K	Buy	135,267 +3,266	+2%	+$19.2K	﹤0.01%	863
2025 Q3	$854K	Hold	132,001	–	–	﹤0.01%	800
2025 Q2	$919K	Hold	132,001	–	–	﹤0.01%	716
2025 Q1	$632K	Hold	132,001	–	–	﹤0.01%	965
2024 Q4	$680K	Sell	132,001 -132,001	-50%	-$526K	﹤0.01%	956
2024 Q3	$958K	Buy	264,002 +56,790	+27%	+$221K	﹤0.01%	1186
2024 Q2	$1M	Buy	207,212 +103,606	+100%	+$499K	﹤0.01%	1060
2024 Q1	$549K	Hold	103,606	–	–	﹤0.01%	1295
2023 Q4	$523K	Hold	103,606	–	–	﹤0.01%	1208
2023 Q3	$535K	Buy	103,606 +3,100	+3%	+$15.7K	﹤0.01%	1145
2023 Q2	$513K	Hold	100,506	–	–	﹤0.01%	1268
2023 Q1	$518K	Buy	100,506 +4,080	+4%	+$26.5K	0.01%	482
2022 Q4	$721	Hold	96,426	–	–	﹤0.01%	720
2022 Q3	$721K	Buy	96,426 +2,407	+3%	+$19.7K	0.01%	424
2022 Q2	$817K	Buy	+94,019	New	+$815K	0.01%	424

Other funds holding ICCC

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return

Steadtrust Allen, Texas $198M AUM 99.37% 1-Year Est. Return

MFIM

Mesirow Financial Investment Management Chicago, Illinois $6.37B AUM 23.22% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Cresset Asset Management's ICCC Position: Q2 2026 in Review

Cresset Asset Management held its ImmuCell (ICCC) position steady in Q2 2026 at 135,267 shares worth $1.36M. The position accounts for ﹤0.01% of the portfolio, ranked #791.

Cresset Asset Management first reported a position in ICCC in Q2 2022 and has held it in 17 quarters since. 31 funds tracked by Wall St. Rank hold ICCC as of Q2 2026.

Cresset Asset Management held 135,267 shares of ImmuCell worth $1.36M as of Q2 2026.
Cresset Asset Management left its ImmuCell share count unchanged in Q2 2026.
ImmuCell made up ﹤0.01% of Cresset Asset Management's portfolio in Q2 2026, its #791 holding.
Cresset Asset Management first reported a position in ImmuCell in Q2 2022 and has held it in 17 quarters since.
31 funds tracked by Wall St. Rank held ImmuCell as of Q2 2026.

Based on Cresset Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.